viral vectors

Pharma

2nd patient dies after Sarepta's DMD gene therapy Elevidys

Sarepta has suspended giving Elevidys to non-ambulatory DMD patients in the commercial setting while it seeks FDA approval of a risk mitigation plan.

Angus Liu Jun 16, 2025 10:58am

Bristol Myers Squibb

BMS calls it quits on vector production at former Novartis plant

May 2, 2025 11:20am

thunderstorm road

Patient dies after receiving Sarepta's DMD gene therapy Elevidys

Mar 18, 2025 10:34am

Novartis

Novartis debuts €40M viral vector plant in Slovenia

Feb 10, 2025 10:57am

Thermo Fisher Plainville

Thermo Fisher will lay off 300 in Massachusetts as cuts continue

Feb 3, 2025 11:21am

Asia

Merck's GLP-1 play; Astellas' AAV deal—Fierce Pharma Asia

Dec 20, 2024 8:51am